医学
前列腺癌
前列腺切除术
谷氨酸羧肽酶Ⅱ
前列腺
雄激素剥夺疗法
泌尿科
前列腺特异性抗原
癌症
肿瘤科
内科学
出处
期刊:Clinical Nuclear Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2021-07-15
卷期号:46 (11): e551-e552
被引量:1
标识
DOI:10.1097/rlu.0000000000003799
摘要
Abstract A 51-year-old man with high-grade ductal variant of prostate cancer with normal prostate-specific antigen (PSA) levels underwent radical prostatectomy. Follow-up 18 F–prostate-specific membrane antigen-targeted ligand 1007 (PSMA-1007) PET/CT revealed enlarged PSMA-expressing left common iliac node. Patient was placed on androgen deprivation therapy and was lost to follow-up. Repeat 18 F-PSMA PET/CT scan after 16 months showed disease progression. PSA levels were still within normal limits. This case highlights the utility of 18 F-PSMA PET/CT for staging and follow-up of patients with this rare ductal variant prostate cancer with normal PSA levels.
科研通智能强力驱动
Strongly Powered by AbleSci AI